William Stohl

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Richard Furie, Michelle Petri, Omid Zamani et al. · Arthritis & Rheumatism · 2011 · 1.6K citations · Full text

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases

Gurtej S. Cheema, Viktor Roschke, David M. Hilbert et al. · Arthritis & Rheumatism · 2001 · 789 citations

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus

Daniel J. Wallace, William Stohl, Richard Furie et al. · Arthritis Care & Research · 2009 · 586 citations · Full text

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations

William Stohl, Samy Metyas, Soon‐Min Tan et al. · Arthritis & Rheumatism · 2003 · 487 citations

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8